ClinicalTrials.gg
RecruitingNCT06962930EQPUpdated Sep 29, 2025

An Online Physical Activity Coaching Intervention for People With PD in Qatar

An interventional study of 8-week personalized self-management program tailored to their individual needs using Engage-Qatar PD. participants will be invited to one face-to-face coaching session and 7 online sessions in Parkinson Disease, sponsored by Qatar University. Recruiting at 3 sites in Qatar. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-09-29.

Sponsored by Qatar University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by May 2026, 6 months ago, but the record still lists the study as recruiting.
  • Started Sep 2025; still recruiting 1 year 2 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Regular exercise can improve function and quality of life as well as have other positive behavioral and health-related benefits in people Parkinson's disease (PD). Despite the benefits, insufficient exercise is common among PD individuals, often due to common barriers, emphasizing the importance of empowering individuals with adequate knowledge and self-management skills.

This project aims to develop "Engage-Qatar PD," an online physical activity self-management program for people with PD in Qatar. Engage-Qatar PD will be grounded in a previously developed coaching intervention used in people with Huntington's disease (Engage HD) and people with PD. The main focus of this project will be the development work to adapt this intervention for online delivery for people with PD and within the Qatari context.

This development stage will entail participatory design, in which users will be actively involved as co-designers to ensure fully the required cultural adaptations. Following this development phase, a pilot randomized controlled trial will be conducted to assess the feasibility, acceptability, and potential benefits of the developed intervention.

The innovative approach proposed for this project would have wide-reaching impact, advancing the development of new therapeutic options. It will deliver a realistic, culturally adapted therapeutic option for people with PD in Qatar that has the potential to be implemented in a variety of healthcare settings and other countries in the region. Importantly, future work could replicate this program in a larger cohort of individuals with other neurodegenerative diseases and extend this work to other countries in the region.

02

Conditions studied

  • Parkinson Disease

Browse trials for

Keywords

  • PD: Parkinson's Disease PA: Physical Activity NDD: Neuro Degenerative Disease QRI: Qatar Rehabilitation Institute
03

In context

Parkinson Disease

4,573 studies on the registry are indexed under Parkinson Disease; 1,086 are open to participants now.

This study's planned enrollment of 40 is close to the median of 40 across 3,353 interventional studies indexed under Parkinson Disease.

Browse Parkinson Disease studies →

Lead sponsor

Qatar University is the lead sponsor of 9 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age above 18 years.
  2. Successful completion of Physical Activity Readiness Questionnaire (PAR-Q), or medical clearance from a neurologist.
  3. Ambulatory for indoor and outdoor mobility with or without an assistive device but without physical assistance.
  4. A neurologist-confirmed diagnosis of PD.
  5. Ability to follow study-related commands.

Exclusion criteria

Exclusion Criteria:

  1. Musculoskeletal injury or a medical condition that would prevent safe participation in an exercise program including failure to pass the PAR-Q test.
  2. The presence of any other neurological conditions.
  3. Acute illness or injury that prevents participation in the intervention.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    intervention group

    Participants will receive an 8-week personalized self-management program. They will be invited to one to 4 face-to-face coaching sessions and 7 remote online sessions. The first session will lay the groundwork for the program, in which an orientation of the features of the online forum will be provided. In addition, goal setting, use of smart watch to record progress, and how to track progress will be discussed. During the remote sessions, the participant and coach will work through informational modules of how to overcome barriers to exercise engagement and how to manage PD symptoms. The coach will provide encouragement in relation to regular physical activity and exercise, and the participant will report on progress related to goals they developed. All participants will receive a wearable watch to help them monitor their physical activity; although wearing the watch is optional, we will recommend that all participants wear it for the 12-week intervention.

    Other: 8-week personalized self-management program tailored to their individual needs using Engage-Qatar PD. participants will be invited to one face-to-face coaching session and 7 online sessions

  • Active comparator
    Control group

    Participants in the control group will receive information on the published recommendations for physical activity for people with PD43. This is the standard information related to physical activity that an individual with PD would be expected to receive from their healthcare provider. To control for the ubiquitous nature of technology, all control participants will also receive Fitbit watches with basic instructions for monitoring their levels of physical activity. As in the intervention group, use of the Fitbit is optional, though we will recommend that both groups wear it for the 8-week intervention. The key ingredients of Engage-Qatar PD are the personalized coaching and self-management approach; thus, the control group will not have access to the Engage-Qatar PD online forum, nor will they have access to coaching or any component of the self-management approach.

    Other: 8-week personalized self-management program tailored to their individual needs using Engage-Qatar PD. participants will be invited to one face-to-face coaching session and 7 online sessions

Interventions

  • Other8-week personalized self-management program tailored to their individual needs using Engage-Qatar PD. participants will be invited to one face-to-face coaching session and 7 online sessions

    The first session will lay the groundwork for the program, in which an orientation of the features of the online forum will be provided. In addition, goal setting, use of watches, and how to track progress will be discussed. During the remote sessions, the participant and coach will work through informational modules of how to overcome barriers to exercise engagement and how to manage PD symptoms. In addition, the coach will provide encouragement in relation to regular physical activity and exercise, and the participant will report on progress related to up to three realistic and individualized goals they developed. key elements: (1) participant-therapist interaction, (2) online forum featuring a physical activity guidebook and workbook, (3) an online platform with personal physical activity database, (4) a wearable smart watch for activity monitors, (5) a video exercise library, (6) online support group, and (7) incorporate adaptation to Arabic culture and available in Arabic

06

What researchers measure

Primary outcomes

  1. Objective Physical activity

    7 day physical activity (i.e., moderate/vigorous activity minutes) using a waist-worn activity monitor (Actigraph)

    Time frame: 7 days

Secondary outcomes

  1. The Physical Activity Scale for Individuals with Physical Disabilities (PASIPD)

    Modified disability version of the 10 item Physical Activity Scale for the Elderly (PASE), Captures information about leisure, household, and work-related physical activity over the preceding 7 days, Developed targeting individuals with visual/auditory and locomotor/SCI disabilities.

    Time frame: less than 5 minutes

  2. International Physical Activity Questionnaire (IPAQ) short form

    This measure will ask about the time spent being physically active in the last 7 days. The purpose of the questionnaires is to provide common instruments that can be used to obtain internationally comparable data on health-related physical activity.

    Time frame: 5 minutes

  3. Six-Minute Walk Test (6MWT)

    The 6-Minute Walk test is a measure of endurance. The Subjects will be asked to walk around the perimeter of a set circuit for a total of 6 minutes.

    Time frame: 10 minutes

  4. The Short Self-Efficacy for Exercise Scale (SSEE)

    is a self-report questionnaire composed of nine items for the assessment of self-efficacy for exercise

    Time frame: 5 minutes

  5. 8-item Parkinson's Disease Questionnaire (PDQ-8)

    The 8-item version of the Parkinson's Disease Questionnaire (PDQ-8) is a shortened version of the 39-item Parkinson's Disease Questionnaire (PDQ-39). It was developed to reduce the respondent burden and increase convenience for use among persons with Parkinson's Disease in clinical settings. PDQ-39 comprises 39 questions from 8 dimensions which include mobility, activities of daily of living, emotional well-being, stigma, social support, cognition, communication, and bodily discomfort.PDQ-8 was constructed by taking one question from each domain of PDQ-39

    Time frame: 5-10 minutes

  6. MDS-UPDRS-II Motor Experiences of Daily Living

    The unified Parkinson's disease rating scale (UPDRS) is used to follow the longitudinal course of Parkinson's disease. The UPD rating scale is the most commonly used scale in the clinical study of Parkinson's disease. . It is consisting of 4 parts one of them is MDS-UPDRS-II Motor Experiences of Daily Living it's about motor aspects of experiences of daily living (M-EDL).

    Time frame: 10 minutes

  7. MDS-UPDRS-III Motor Examination

    The unified Parkinson's disease rating scale (UPDRS) is used to follow the longitudinal course of Parkinson's disease. The UPD rating scale is the most commonly used scale in the clinical study of Parkinson's disease. It is consists of 4 parts one of them is MDS-UPDRS-III Motor Examination its assesses the motor signs of PD

    Time frame: 15 minutes

  8. Levodopa Equivalent Daily Doses (LEDD)

    The Levodopa Equivalent Daily Dose (LEDD) is a useful calculation for comparing the doses of different Parkinson's disease medications to their equivalent amount of Levodopa. This helps clinicians to evaluate the overall dopaminergic load a patient is receiving. Various Parkinson's medications, such as Levodopa, Dopamine Agonists, and MAO-B inhibitors, can be converted into an equivalent dose of Levodopa using standard conversion factors.

    Time frame: 5 minutes

  9. Mini Balance Evaluation Systems Test (Mini-BEST)

    balance assessment tool is a shortened version of the Balance Evaluation Systems Test (BESTest) consists of 14 items, including 4 of the 6 sections (anticipatory postural adjustments, reactive postural control, sensory orientation, and dynamic gait) from the BESTest. It aims to target and identify 6 different balance control systems so that specific rehabilitation approaches can be designed for different balance deficits. The BESTest was shortened based on factor analysis to include dynamic balance only and to improve clinical utilization.

    Time frame: 10-15 minutes

  10. Five Times Sit to Stand Test (5TSTS)

    The Five Times Sit to Stand Test measures one aspect of transfer skill. The test provides a method to quantify functional lower extremity strength and identify movement strategies a patient uses to complete transitional movements.

    Time frame: Less than 5 minutes Depends on the number of trials

  11. the Montréal Cognitive Assessment Scale (MOCA)

    (MoCA) was designed as a rapid screening instrument for mild cognitive dysfunction. It assesses different cognitive domains: attention and concentration, executive functions, memory, language, vasoconstrictional skills, conceptual thinking, calculations, and orientation. The MoCA may be administered by anyone who understands and follows the instructions

    Time frame: 10 minutes

  12. the Symbol Digit Modalities Test

    a commonly used test to assess psychomotor speed, which measures processing speed as well as motor speed. requires an individual to substitute digits for abstract symbols using a reference key. Performance is also affected by attention, visual scanning and tracking, and working memory .The SDMT has excellent psychometric properties, with high reliability and validity .

    Time frame: less than 5 minutes

  13. the Stroop Color-Word Interference

    The Stroop Test is a measure of working memory and attention. When the colours and words a conflicting, the brain must work hard to filter out competing signals. Reading is such an automatic task that the brain needs to actively inhibit it and direct its attention instead to saying the colour of the letters. The resulting delay is called the Stroop Effect. When the colours and words match, or when the words are neutral, there is no conflicting information for the brain to have to filter out.

    Time frame: 5 minutes

  14. Pittsburgh sleep quality index (PSQI)

    is a self-report questionnaire that assesses sleep quality over a 1-month time interval. The measure consists of 19 individual items, creating 7 components that produce one global score It is a valuable tool for assessing sleep quality as it captures multiple dimensions of sleep, including both subjective experiences and objective parameters. It allows researchers and healthcare providers alike to obtain a comprehensive understanding of an individual's sleep patterns and disturbances.

    Time frame: 5-10 minutes

  15. the Hospital Anxiety-Depression scale (HADS)

    is a 14-item scale, with seven items relating to anxiety and seven relating to depression.

    Time frame: 2-5 minutes

  16. 10 Meter Walk Test (10MWT)

    The 10 Meter Walking Test (10 MWT) assesses short duration walking speed (m/s). It has been used various patient populations including stroke, Parkinson's disease and general neurologic movement disorders. The 10 Meter Walking Test (10 MWT) is clinician-administered, and measures the time required to walk 10 meters. The test is performed using a "flying start": the patient walks 14m, and the time is measured for the intermediate 10 meters.

    Time frame: 5 minutes

  17. Barriers to Being Active Quiz (BBAQ)

    is a structured questionnaire that measures the barriers to being active consists of 21 questions.

    Time frame: 5-10 minutes

  18. Barriers Subscale of the Physical Fitness

    It a 21-item measure assessing the following barriers to physical activity: 1) lack of time, 2) social influence, 3) lack of energy, 4) lack of willpower, 5) fear of injury, 6) lack of skill, and 7) lack of resources. Each domain contains 3 items, with a total score range of 0 to 63. Respondents rate the degree of activity interference on a 4-point scale, ranging from 0 = "very unlikely" to 3 = "very likely."

    Time frame: 5-10 minutes

  19. The Modified Fatigue Impact Scale

    self-report questionnaire provides an assessment of the effects of fatigue in terms of physical, cognitive, and psychosocial functioning and it consists of 21 items.

    Time frame: 5-10 minutes

  20. Barriers to Health Promoting Activities for Disabled Persons Scale (BHADP)

    an 18-item, 4-point scale to measure individual barriers to taking care of health. The original scale had 16 items; two additional barrier items, these items address the weather and lack of help from health care professionals. Respondents are asked to indicate how often listed barriers keep them from taking care of their health. Items include intrapersonal, interpersonal, and environmental barriers. Examples of barriers include being too tired, having other responsibilities, and lack of transportation.

    Time frame: 5-10 min

  21. 7 day physical activity (i.e., step count) using a waist-worn activity monitor (Actigraph)

    Time frame: 7 days

07

Study locations

2 of 3 sites recruiting
  • Qatar Rehabilitation Institution
    Doha, 0000, Qatar
    Recruiting
    • Hanan Khalil Prof Professor, phd · Contact+97430087097
  • Rumaila Hospital
    Doha, 0000, Qatar
    Recruiting
  • Qatar University
    Doha, 2713, Qatar
    Not yet recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 29, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06962930
Lead sponsor
Qatar University
Responsible party
Hanan Khalil (professor, Qatar University) — Principal investigator
First posted
May 8, 2025
Start date
Sep 10, 2025
Primary completion
May 10, 2026 (estimated)
Completion
Sep 10, 2026 (estimated)
Last update
Sep 29, 2025

Study contacts

Hanan Khalil prof Professor, phd
Contact
hkhalil@qu.edu.qa
+974 30087097

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion